Karolinska Institutet Inaugurates Research Centre in Hong Kong

By establishing this node in Hong Kong, Karolinska Institutet (KI) is strengthening its research within regenerative medicine.

”This is a natural step for KI, given our ambition of continuing to be a leading international university in medical research. Hong Kong is a global hub for research and innovation and provides unique opportunities for collaboration and knowledge exchange. By establishing this new centre, we hope to take a significant step forward in an area that can have important future implications for human health,” says Karin Dahlman-Wright, Karolinska Institutet's Acting Vice-Chancellor.

The Ming Wai Lau Centre for Reparative Medicine will consist of two nodes, one in Stockholm and one in Hong Kong. Under KI's leadership, the centre will conduct basic research using technologies that are relevant for regenerative medicine. One of the primary goals is to develop new knowledge and tools to repair damaged or lost tissue.

”We believe that people who are skilled in this area will be attracted by the new centre. Research today is all about partnerships, especially for newly established groups. Much of the best stem cell research today is being done in Asia, and KI wants to be a part of it,” says Ola Hermanson, scientific director of the new centre and researcher at KI's Department of Neuroscience. Hermanson is to lead six team leaders at the Stockholm node to work on topics relevant to the centre mission.

The centre has been fully funded through a donation from the Hong Kong-based businessman Ming Wai Lau. The research projects in Lau Centre range from biomedical engineering, gene-editing, RNA technology, to the next-generation single-cell analysis/bioinformatics for the advanced development and translation of the specialty areas of stem cell-based regeneration of the heart, liver and nervous systems.

Ronald Li, whose expertise is in cell-based heart regeneration, serves as the executive director based at the centre located in the Hong Kong Science Park. International recruitment of four team leaders, along with 50 staff, is close to completion or in progress.

Hermanson and Li have been working closely together, and will ensure that the two nodes synergistically interact.

”I have deep belief in the impact that stem cell research will bring to the medical field and the human race as a whole. Hong Kong is equipped with all the favourable conditions to become a regional hub in this highly specialised area and I take great pride in supporting this meaningful initiative,” says Lau Ming Wai, donor of the new centre. 'The establishment of this centre in Science Park will provide the intended practitioners in Hong Kong a springboard to take their research projects to the world stage in reparative medicine.”